The MM+M Podcast

MM+M Podcast 11.2.21: RDA’s Michael Nace

Nace, brand director for Rare Disease Advisor (an MM+M sister brand), joins Marc Iskowitz to discuss trends shaping the awareness and commercialization of rare disease products.

HCP measurability and insights

Advertisers have come to expect a deeper level of understanding on performance for their campaigns. Traditional metrics provide insights on engagements, clicks, views, etc. Those are singular events. Rightfully, advertisers want to understand the full customer journey and the impacts after seeing an ad or engaging with a deeper engagement tactic.

MM+M Podcast 10.26.21: PulsePoint’s Maria Simeone

Simeone, VP of marketing at PulsePoint, joins Marc Iskowitz to explain findings from its half-year State of Health Media report, including keys for healthcare marketers to reach HCP and patient audiences in 2022.

Engaging partners early in the commercialization process is key to success

Creating a solid branding foundation and market access strategy will pay off down the road.

MM+M Podcast 10.21.21: Issue One’s Danielle Caputo

Caputo, legislative and programs counsel for Washington watchdog group Issue One, talks about “dark money” and ethics in the advertising about Medicare drug-price negotiations.